Abstract:Live cell assays provide real-time data of cellular responses. In combination with microfluidics, applications such as automated and high-throughput drug screening on live cells can be accomplished in small devices. However, their application in point-of-care testing (POCT) is limited by the requirement for bulky equipment to maintain optimal cell culture conditions. In this study, we propose a POCT device that allows on-site cell culture and high-throughput drug screening on live cells. We first observe that cell viabilities are substantially affected by liquid evaporation within the microfluidic device, which is intrinsic to the polydimethylsiloxane (PDMS) material due to its hydrophobic nature and nanopatterned surface. The unwanted PDMS-liquid-air interface in the cell culture environment can be eliminated by maintaining a persistent humidity of 95-100% or submerging the whole microfluidic device under water. Our results demonstrate that in the POCT device equipped with a water tank, both primary cells and cell lines can be maintained for up to 1 week without the need for external cell culture equipment. Moreover, this device is powered by a standard alkali battery and can automatically screen over 5000 combinatorial drug conditions for regulating neural stem cell differentiation. By monitoring dynamic variations in fluorescent markers, we determine the optimal doses of platelet-derived growth factor and epidermal growth factor to suppress proinflammatory S100A9-induced neuronal toxicities. Overall, this study presents an opportunity to transform lab-on-a-chip technology from a laboratory-based approach to actual point-of-care devices capable of performing complex experimental procedures on-site and offers significant advancements in the fields of personalized medicine and rapid clinical diagnostics.

Nephrocyte-neurocyte interaction and cellular metabolic analysis on membrane-integrated microfluidic device

Micro Chip with Nanostructured Membranes for Cell Morphology Monitoring

The Application of SAM Technology in Biocompatibility Design of Cell-Based Biosensor

Cell Signaling Analysis by Mass Spectrometry under Coculture Conditions on an Integrated Microfluidic Device

Integrated microfluidic system for cell co-culture and simulation of drug metabolism

Drug evaluations using a novel microphysiometer based on cell-based biosensors

An Agar Gel Membrane-Pdms Hybrid Microfluidic Device for Long Term Single Cell Dynamic Study

Cell Analysis on Microfluidics Combined with Mass Spectrometry

Strategy for signaling molecule detection by using an integrated microfluidic device coupled with mass spectrometry to study cell-to-cell communication.

Multifunctional Regulation of 3D Cell-Laden Microsphere Culture on an Integrated Microfluidic Device

Efficient Drug Screening and Nephrotoxicity Assessment on Co-culture Microfluidic Kidney Chip

Single-cell Metabolite Analysis on a Microfluidic Chip

A microfluidic platform culturing two cell lines paralleled under in-vivo like fluidic microenvironment for testing the tumor targeting of nanoparticles

Quantitative Study of the Dynamic Tumor-Endothelial Cell Interactions Through an Integrated Microfluidic Coculture System.

From Chips-in-Lab to Point-of-Care Live Cell Device: Development of a Microfluidic Device for On-Site Cell Culture and High-Throughput Drug Screening

A versatile valve-enabled microfluidic cell co-culture platform and demonstration of its applications to neurobiology and cancer biology

Development of Cell Culture and Analysis on Microfluidic Devices

Microfluidic 3D cell culture: potential application for tissue-based bioassays

Microfluidic application-specific integrated device for monitoring direct cell-cell communication via gap junctions between individual cell pairs

Imitation of drug metabolism in cell co-culture microcapsule model using a microfluidic chip platform coupled to mass spectrometry

Development of Cell Metabolite Analysis on Microfluidic Platform